Search

everythinglearnresearchcommunity

for

Search:↓

A child had a rare case of scarring hair loss with skin disease, which is hard to treat and stressful.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Early diagnosis and new treatments are crucial to prevent permanent hair loss in scarring alopecia.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

Accurate diagnosis is crucial for effective treatment of hair loss.

The report found a new type of hair loss in African-American women that affects more areas of the scalp than previously thought.

The document concludes that early and accurate diagnosis of hair loss on the top of the scalp in Black men is important to distinguish CCCA from other types of hair loss.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

DCPA is a chronic skin condition affecting the legs, often misdiagnosed, and needs more research for better understanding and treatment.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.

CCCA and lichen planopilaris have similar histological features, making them hard to distinguish.

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Combining FUE hair transplantation with PRP improves hair density and patient satisfaction in scarring alopecia.

The most effective way to diagnose non-scarring hair loss is by transverse sectioning, and some cases, particularly in males with inflammation around hair follicles, might be curable.

Higher levels of β-carotene and vitamin E may help prevent certain types of hair loss.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

The letter suggests that the study's comparison group might have affected the results and calls for larger, more detailed future research.

Scarring alopecia causes permanent hair loss, and treatment aims to reduce inflammation and stop it from getting worse.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

The absence of functional sebaceous glands causes hair follicle destruction and scarring alopecia.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Hair restoration surgery can potentially treat primary scarring alopecias, but it's important to start early medication, ensure patient remission before transplant, and monitor after surgery.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Early diagnosis and aggressive treatment are important for managing scarring alopecia; hair transplantation's effectiveness is uncertain.